Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
InspireMD, Inc. stock logo
NSPR
InspireMD
$2.26
+1.8%
$2.43
$1.99
$3.80
$69.24M0.5767,508 shs44,033 shs
Avita Medical Inc. stock logo
RCEL
Avita Medical
$5.61
+8.5%
$6.35
$4.71
$14.16
$136.67M1.52189,185 shs347,946 shs
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$30.30
+3.9%
$30.02
$25.86
$39.08
$259.26M1.328,892 shs50,012 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$9.63
+2.1%
$9.06
$8.15
$22.40
$262.60M2.07191,368 shs140,965 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
InspireMD, Inc. stock logo
NSPR
InspireMD
-1.55%-2.20%-11.20%-16.85%-7.11%
Avita Medical Inc. stock logo
RCEL
Avita Medical
-6.26%-2.27%-15.38%-32.59%-35.94%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-2.36%+2.75%-1.09%+7.96%+8.60%
ZimVie Inc. stock logo
ZIMV
ZimVie
-7.91%+0.86%+0.53%+3.29%-48.61%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
InspireMD, Inc. stock logo
NSPR
InspireMD
3.3632 of 5 stars
3.54.00.00.02.72.50.6
Avita Medical Inc. stock logo
RCEL
Avita Medical
0.8507 of 5 stars
3.40.00.00.00.00.00.6
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
1.9174 of 5 stars
3.51.00.00.00.01.70.6
ZimVie Inc. stock logo
ZIMV
ZimVie
1.8927 of 5 stars
3.33.00.00.00.01.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.5099.12% Upside
Avita Medical Inc. stock logo
RCEL
Avita Medical
2.75
Moderate Buy$16.50194.12% Upside
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
3.00
Buy$49.5063.37% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.67
Moderate Buy$16.3369.61% Upside

Current Analyst Ratings Breakdown

Latest NSPR, SMTI, RCEL, and ZIMV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/6/2025
Avita Medical Inc. stock logo
RCEL
Avita Medical
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$19.00
5/15/2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$51.00 ➝ $53.00
5/15/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $10.00
5/12/2025
InspireMD, Inc. stock logo
NSPR
InspireMD
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$4.50 ➝ $4.00
4/10/2025
Avita Medical Inc. stock logo
RCEL
Avita Medical
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$22.00 ➝ $22.00
4/10/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$16.00
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/9/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
InspireMD, Inc. stock logo
NSPR
InspireMD
$7.03M9.85N/AN/A$1.83 per share1.23
Avita Medical Inc. stock logo
RCEL
Avita Medical
$64.25M2.31N/AN/A$0.17 per share33.00
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
$86.67M3.11N/AN/A$4.45 per share6.81
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M0.60$1.90 per share5.08$13.83 per share0.70
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.79N/AN/AN/A-413.96%-69.42%-57.68%N/A
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$61.85M-$2.19N/AN/AN/A-79.61%-632.62%-71.72%8/6/2025 (Estimated)
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$9.66M-$1.34N/AN/AN/A-12.48%-29.22%-13.20%8/11/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.71N/AN/A-4.40%5.53%2.84%7/31/2025 (Estimated)

Latest NSPR, SMTI, RCEL, and ZIMV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/31/2025Q2 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.2285N/AN/AN/A$112.82 millionN/A
5/14/2025Q1 2025
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
-$0.31-$0.41-$0.10-$0.41$23.48 million$23.43 million
5/8/2025Q1 2025
Avita Medical Inc. stock logo
RCEL
Avita Medical
-$0.39-$0.53-$0.14-$0.53$33.15 million$18.51 million
5/8/2025Q1 2025
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.21$0.27+$0.06-$0.05$113.10 million$112.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
Avita Medical Inc. stock logo
RCEL
Avita Medical
N/AN/AN/AN/AN/A
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
Avita Medical Inc. stock logo
RCEL
Avita Medical
9.39
2.09
1.72
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
1.18
2.77
2.54
ZimVie Inc. stock logo
ZIMV
ZimVie
0.58
2.14
1.48

Institutional Ownership

CompanyInstitutional Ownership
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
Avita Medical Inc. stock logo
RCEL
Avita Medical
27.66%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
8.10%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
InspireMD, Inc. stock logo
NSPR
InspireMD
34.06%
Avita Medical Inc. stock logo
RCEL
Avita Medical
2.80%
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
42.60%
ZimVie Inc. stock logo
ZIMV
ZimVie
5.41%
CompanyEmployeesShares OutstandingFree FloatOptionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5030.64 million18.33 millionOptionable
Avita Medical Inc. stock logo
RCEL
Avita Medical
13026.43 million25.70 millionOptionable
Sanara MedTech Inc. stock logo
SMTI
Sanara MedTech
608.89 million5.10 millionNot Optionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77027.85 million26.34 millionOptionable

Recent News About These Companies

Wall Street Zen Upgrades ZimVie (NASDAQ:ZIMV) to "Strong-Buy"
ZimVie: Screening Cheap (Rating Upgrade)
ZimVie Inc. (ZIMV) Q1 2025 Earnings Call Transcript
ZimVie Reports First Quarter 2025 Financial Results
Q1 2025 ZimVie Inc Earnings Call
ZimVie announces launch of its Immediate Molar Implant system in US
ZimVie launches molar implant system
Needham Remains a Hold on ZimVie Inc (ZIMV)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
InspireMD stock logo

InspireMD NYSE:NSPR

$2.26 +0.04 (+1.80%)
Closing price 04:00 PM Eastern
Extended Trading
$2.26 0.00 (0.00%)
As of 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Avita Medical stock logo

Avita Medical NASDAQ:RCEL

$5.61 +0.44 (+8.51%)
Closing price 04:00 PM Eastern
Extended Trading
$5.61 0.00 (0.00%)
As of 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Sanara MedTech stock logo

Sanara MedTech NASDAQ:SMTI

$30.30 +1.13 (+3.87%)
Closing price 04:00 PM Eastern
Extended Trading
$29.60 -0.70 (-2.31%)
As of 05:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$9.63 +0.20 (+2.12%)
As of 04:00 PM Eastern

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.